Vitamin B6 deficiency in maintenance dialysis patients: metabolic effects of repletion
Open Access
- 1 July 1980
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 33 (7), 1612-1619
- https://doi.org/10.1093/ajcn/33.7.1612
Abstract
Vitamin B6 deficiency is often present in uremic patients, particularly those undergoing dialysis. The contribution of this deficiency to abnormal amino acid and lipid metabolism and to depressed immune function in maintenance dialysis patients was studied. EGOT activity and EGOT indices (i.e., the ratio of activity of EGOT stimulated with exogenous pyridoxal-5′-phosphate to EGOT activity alone) were measured in 15 dialysis patients (D) ingesting at least 2 mg pyridoxine HCl/day and in nine controls (C). EGOT activity was lower (389 ± 18 U/liter) in D as compared to (534 ± 41 U/liter) in C (P < 0.01). EGOT indices in D (1.68 ± 0.07) and C (1.59 ± 0.08) did not differ significantly. After 14 days of 300 mg/day pyridoxine HCl (B6) oral supplementation, EGOT activity increased to a similar range in D (800 ± 47 U/liter) and C (867 ± 43 U/liter). Immune responsiveness as assessed by spontaneous reactive lymphocyte blastogenesis and lymphocyte reactivity to Con A and phytohemagglutinin was within the normal range in D before and after B6. Serum high-density lipoprotein levels increased significantly in D after B6 (P < 0.05). Serum cholesterol and triglyceride levels did not change. Disorders of amino acid metabolism in D were studied by measuring fasting plasma amino acid levels and metabolic clearance rates of essential amino acids. Metabolic clearance rate was significantly lower in D (P 6. Fasting plasma levels of valine, leucine, tryptophan, serine, glutamine, alanine, and tyrosine were significantly lower in D compared to C. After pyridoxine supplementation, plasma valine, leucine, serine, glutamine, and alanine increased to C levels, while tryptophan and tyrosine did not change. Changes in fasting plasma amino acid and serum high-density lipoprotein levels after correction of the biochemical deficiency of vitamin B6 in D indicates that vitamin B6 deficiency may contribute significantly to the pathogenesis of the abnormal amino acid and lipid metabolism in D.Keywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics of essential amino acids in chronic dialysis patientsThe American Journal of Clinical Nutrition, 1978
- Defective Triglyceride Removal in Lipemia Associated with Peritoneal Dialysis and HaemodialysisAnnals of Internal Medicine, 1976
- Vitamin B6 deficiency in uremiaThe American Journal of Clinical Nutrition, 1975
- Vitamin B6 deficiency in uremia and its implications for the depression of immune responsesKidney International, 1974
- In vitro Cellular Immunity and in vivo Delayed Hypersensitivity in Uremic Patients Maintained on HemodialysisInternational Archives of Allergy and Immunology, 1974
- Quantitative changes in plasma amino acids in patients with renal diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- Immune processes in vitamin deficiency statesThe American Journal of Clinical Nutrition, 1971
- Effect of Vitamin B6 Depletion in Adult Man on the Plasma Concentration and the Urinary Excretion of Free Amino AcidsJournal of Nutrition, 1971
- Plasma amino acid imbalance in patients with chronic renal failure on intermittent dialysisClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- THE EFFECT OF UREMIC BLOOD ON MIXED LEUKOCYTE REACTIONS AND ON CULTURES OF LEUKOCYTES WITH PHYTOHEMAGGLUTININTransplantation, 1967